You are here

Histomorphometric Assessment of Implant Coating with A Mixture of Strontium Chloride and Hydroxyapatite at Different Concentration

Journal Name:

Publication Year:

Abstract (2. Language): 
Background/purpose: Surface properties are one of the major keys of successful implant osseointegration in addition to mechanical strength and excellent biocompatibility of implant material. The purpose of this study is to make histological and histomorphometric analysis of an implant coated with strontium chloride (SrCl2) mixed with hydroxyapatite (HA) at different concentrations, in rabbit tibia at 2 and 6 weeks of implantation time. Method: 48 commercially pure titanium screw shaped implants were placed in 24 healthy adult New Zeeland rabbits, each rabbit received 2 implants; one coated with mixture 1 (25% HA and 75% SrCl2) and the other coated with mixture 2 (75% HA and 25% SrCl2). Twelve rabbits were sacrificed at 2 weeks of healing and other twelve after 6 weeks. The new bone area and number of cells (osteoblast and osteoclast) were assessed by light microscope. Result: Statistical analysis showed significant differences in new bone formation ratio after 2 weeks of healing and non-significant differences after 6 weeks of healing. Data also suggested that osteoblast was increased, and osteoclast was decreased in mixture 2 (75% HA and 25% SrCl2) more than mixture 1 (25% HA and 75% SrCl2). Conclusion: There was a significantly higher new bone formation ratio of mix 2 (25%Sr-75%HA) coated Cp-Ti implants than mix 1 (75% Sr- 25% HA) coated Cp-Ti implant at 2 weeks healing period, also there was an increase in new bone formation ratio with time for both coated materials (SrCl2) implants.
152
157

REFERENCES

References: 

[1] Teixeira, Eduardo Rolim. Superfície dos implantes: o estágio atual. In: Implantes Osseointegrados: cirurgia e
prótese. Dinato JC, Polido WD. São Paulo: Artes Médicas. pp. 63-80.
[2] Bhattarai, Shanta Raj, et al. “Novel production method and in-vitro cell compatibility of porous Ti-6Al-4V alloy
disk for hard tissue engineering.” Journal of Biomedical Materials Research Part A, Vol. 86, No. 2, 2008, pp.
289-99.
[3] Vasconcellos, Luana MR, et al. “Design of dental implants, influence on the osteogenesis and fixation.” Journal
of Materials Science: Materials in Medicine, Vol. 19, No. 8, 2008, pp. 2851-57.
[4] Vasconcellos, Luana Marotta Reis de, et al. “Porous titanium scaffolds produced by powder metallurgy for
biomedical applications.” Materials Research, Vol. 11, No. 3, 2008, pp. 275-80.
[5] Vasconcellos, Luana Marotta Reis de, et al. “Porous titanium associated with CaP coating: In vivo and in vitro
osteogenic performance.” Materials Research, AHEAD, 2017.
[6] Vasconcellos, Luana Marotta Reis de, et al. “Evaluation of bone ingrowth into porous titanium implant:
histomorphometric analysis in rabbits.” Brazilian Oral Research, Vol. 24, No. 4, 2010, pp. 399-405.
[7] Wazen, Rima M., et al. “Initial evaluation of bone ingrowth into a novel porous titanium coating.” Journal of
Biomedical Materials Research Part B: Applied Biomaterials, Vol. 94, No. 1, 2010, pp. 64-71.
[8] Bottino, Marco C., et al. “Processing, characterization, and in vitro/in vivo evaluations of powder metallurgy
processed Ti-13Nb-13Zr alloys.” Journal of Biomedical Materials Research Part A, Vol. 88, No. 3, 2009, pp.
689-96.
[9] Bottino, M.C., et al. “Histomorphologic evaluation of Ti–13Nb–13Zr alloys processed via powder metallurgy. A
study in rabbits.” Materials Science and Engineering: C, Vol. 28, No. 2, 2008, pp. 223-27.
[10] Santos, D.R., et al. “Isochronal sintering of the blended elemental Ti–35Nb alloy.” Materials Science and
Engineering: A, Vol. 472, No. 1, 2008, pp. 193-97.
[11] Lee, Jeong-Hoon, Su-Gwan Kim, and Sung-Chul Lim. “Histomorphometric study of bone reactions with
different hydroxyapatite coating thickness on dental implants in dogs.” Thin Solid Films, Vol. 519, No. 15, 2011,
pp. 4618-22.
[12] Rosenthal, Harold L., Maura M. Eves, and Olive Ann Cochran. “Common strontium concentrations of mineralized
tissues from marine and sweet water animals.” Comparative Biochemistry and Physiology, Vol. 32, No. 3, 1970,
pp. 445-50.
[13] Rosenthal, Harold L., Olive Ann Cochran, and Maura M. Eves. “Strontium content of mammalian bone, diet and
excreta.” Environmental Research, Vol. 5, No. 2, 1972, pp. 182-91.
[14] Dahl, S.G., et al. “Incorporation and distribution of strontium in bone.” Bone, Vol. 28, No. 4, 2001, pp. 446-53.
[15] Skoryna, Stanley C. “Metabolic aspects of the pharmacologic use of trace elements in human subjects with
specific reference to stable strontium.” Trace Subst Environ Health, Vol. 18, No. 3, 1984, p. 23.
[16] Bonnelye, Edith, et al. “Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition
of osteoclast formation and resorption in vitro.” Bone, Vol. 42, No. 1, 2008, pp. 129-38.
[17] Bain, S.D., et al. “Strontium ranelate improves bone strength in ovariectomized rat by positively influencing
bone resistance determinants.” Osteoporosis International, Vol. 20, No. 8, 2009, pp. 1417-28.
Ghasak H, et al. Int J Med Res Health Sci 2018, 7(1): 152-157
157
[18] Arlot, Monique E., et al. “Histomorphometric and μCT analysis of bone biopsies from postmenopausal
osteoporotic women treated with strontium ranelate.” Journal of Bone and Mineral Research, Vol. 23, No. 2,
2008, pp. 215-22.
[19] Canalis, E., et al. “The divalent strontium salt S12911 enhances bone cell replication and bone formation in
vitro.” Bone, Vol. 18, No. 6, 1996, pp. 517-23.
[20] Caverzasio, Joseph. “Strontium ranelate promotes osteoblastic cell replication through at least two different
mechanisms.” Bone, Vol. 42, No. 6, 2008, pp. 1131-36.
[21] Chattopadhyay, Naibedya, et al. “The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced
osteoblast proliferation.” Biochemical Pharmacology, Vol. 74, No. 3, 2007, pp. 438-47.
[22] Fromigué, Olivia, et al. “Calcium sensing receptor-dependent and receptor-independent activation of osteoblast
replication and survival by strontium ranelate.” Journal of Cellular and Molecular Medicine, Vol. 13, No. 8b,
2009, pp. 2189-99.
[23] Barbara, A., et al. “Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic
cells.” Metabolism, Vol. 53, No. 4, 2004, p.p. 532-37.
[24] Choudhary, Shilpa, et al. “Strontium ranelate promotes osteoblastic differentiation and mineralization of murine
bone marrow stromal cells: involvement of prostaglandins.” Journal of Bone and Mineral Research, Vol. 22, No.
7, 2007, pp. 1002-10.
[25] Zhu, Ling-Ling, et al. “Induction of a program gene expression during osteoblast differentiation with strontium
ranelate.” Biochemical and Biophysical Research Communications, Vol. 355, No. 2, 2007, pp. 307-11.
[26] Häuselmann, H.J., and R. Rizzoli. “A comprehensive review of treatments for postmenopausal
osteoporosis.” Osteoporosis International, Vol. 14, No. 1, 2003, pp. 2-12.
[27] Shapiro, Frederic. “Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts
and surface osteoblasts.” European Cells & Materials, Vol. 15, No. 53, 2008, p. e76.
[28] Baek, S.M., S.G. Kim, and S.C. Lim. “Histomorphometric Evaluation of New Bone Formation around a Magnetic
Implant in Dogs.” Implant, Vol. 15, No. 1, 2011, pp. 22-30.
[29] Barrère, Florence, Clemens A. van Blitterswijk, and Klaas de Groot. “Bone regeneration: molecular and cellular
interactions with calcium phosphate ceramics.” International Journal of Nanomedicine, Vol. 1, No. 3, 2006, p. 317.
[30] Väänänen, Kalervo. “Mechanism of osteoclast mediated bone resorption-rationale for the design of new
therapeutics.” Advanced Drug Delivery Reviews, Vol. 57, No. 7, 2005, pp. 959-71.
[31] Capuccini, C., et al. “Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: In
vitro osteoblast and osteoclast response.” Acta Biomaterialia, Vol. 4, No. 6, 2008, pp. 1885-93.

Thank you for copying data from http://www.arastirmax.com